Immunovant, Inc. (IMVT) vs Ligand Pharmaceuticals Incorporated (LGND)

• Immunovant, Inc. IMVT 26.73 ▼ −2.84%
• Ligand Pharmaceuticals Incorporated LGND 295.54 ▼ −0.99%

Immunovant, Inc. and Ligand Pharmaceuticals Incorporated are both Biotechnology companies. Immunovant, Inc. and Ligand Pharmaceuticals Incorporated are of similar size ($6.0B and $5.7B). Immunovant, Inc. has negative trailing earnings, so its P/E is not meaningful; Ligand Pharmaceuticals Incorporated trades at 29.5×. Ligand Pharmaceuticals Incorporated has the higher net margin (67.9% vs 0.00%) and the higher return on invested capital (8.19% vs 0.00%). Across the 14 metrics below, Ligand Pharmaceuticals Incorporated leads on 13 and Immunovant, Inc. on 1.